Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation

Gege Xu, Jasmine C C Davis, Elisha Goonatilleke, Jennifer T. Smilowitz, J. Bruce German, Carlito B Lebrilla

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: The quantitation of human milk oligosaccharides (HMOs) is challenging because of the structural complexity and lack of standards. Objective: The objective of our study was to rapidly measure the absolute concentrations of HMOs in milk using LC-mass spectrometry (MS) and to determine the phenotypic secretor status of the mothers. Methods: This quantitative method for measuring HMO concentration was developed by using ultraperformance LC multiple reaction monitoring MS. It was validated and applied to milk samples from Malawi (88 individuals; 88 samples from postnatal month 6) and the United States (Davis, California; 45 individuals, mean age: 32 y; 103 samples collected on postnatal days 10, 26, 71, or 120, repeated measures included). The concentrations of a(1,2)-fucosylated HMOs were used to determine the mothers' phenotypic secretor status with high sensitivity and specificity. We used Friedman's test and Wilcoxon's signed rank test to evaluate the change in HMOconcentration during the course of lactation, and Student's t test was used to compare secretors and nonsecretors. Results: A decrease (P < 0.05) in HMO concentration was observed during the course of lactation for the US mothers, corresponding to 19.3 ± 2.9 g/L for milk collected on postnatal day 10, decreasing to 8.53 ± 1.18 g/L on day 120 (repeated measures; n = 14). On postnatal day 180, the total concentration of HMOs in Malawi milk samples from secretors (6.46 ± 1.74 mg/mL) was higher (P < 0.05) than that in samples from nonsecretors (5.25 ± 2.55 mg/mL ). The same trend was observed for fucosylated species; the concentrationwas higher in Malawimilk samples from secretors (4.91 ± 1.22mg/mL) than from nonsecretors (3.42 ± 2.27 mg/mL) (P < 0.05). Conclusions: HMOs significantly decrease during the course of lactation. Secretor milk contains higher concentrations of total and fucosylated HMOs than does nonsecretor milk. These HMO concentrations can be correlated to the health of breastfed infants in order to investigate the protective effects ofmilk components. The trialswere registered at clinicaltrials.gov as NCT01817127 and NCT00524446.

Original languageEnglish (US)
Pages (from-to)117-124
Number of pages8
JournalJournal of Nutrition
Volume147
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Human Milk
Oligosaccharides
Lactation
Milk
Malawi
Mothers
Mass Spectrometry
Nonparametric Statistics
Students
Sensitivity and Specificity

Keywords

  • Fucosylation
  • Human milk oligosaccharides
  • Lactation
  • Mass spectrometry
  • Secretor

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Xu, G., Davis, J. C. C., Goonatilleke, E., Smilowitz, J. T., German, J. B., & Lebrilla, C. B. (2017). Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation. Journal of Nutrition, 147(1), 117-124. https://doi.org/10.3945/jn.116.238279

Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation. / Xu, Gege; Davis, Jasmine C C; Goonatilleke, Elisha; Smilowitz, Jennifer T.; German, J. Bruce; Lebrilla, Carlito B.

In: Journal of Nutrition, Vol. 147, No. 1, 2017, p. 117-124.

Research output: Contribution to journalArticle

Xu, G, Davis, JCC, Goonatilleke, E, Smilowitz, JT, German, JB & Lebrilla, CB 2017, 'Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation', Journal of Nutrition, vol. 147, no. 1, pp. 117-124. https://doi.org/10.3945/jn.116.238279
Xu, Gege ; Davis, Jasmine C C ; Goonatilleke, Elisha ; Smilowitz, Jennifer T. ; German, J. Bruce ; Lebrilla, Carlito B. / Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation. In: Journal of Nutrition. 2017 ; Vol. 147, No. 1. pp. 117-124.
@article{4bd443798c23405a9f6b6287d2e3a03f,
title = "Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation",
abstract = "Background: The quantitation of human milk oligosaccharides (HMOs) is challenging because of the structural complexity and lack of standards. Objective: The objective of our study was to rapidly measure the absolute concentrations of HMOs in milk using LC-mass spectrometry (MS) and to determine the phenotypic secretor status of the mothers. Methods: This quantitative method for measuring HMO concentration was developed by using ultraperformance LC multiple reaction monitoring MS. It was validated and applied to milk samples from Malawi (88 individuals; 88 samples from postnatal month 6) and the United States (Davis, California; 45 individuals, mean age: 32 y; 103 samples collected on postnatal days 10, 26, 71, or 120, repeated measures included). The concentrations of a(1,2)-fucosylated HMOs were used to determine the mothers' phenotypic secretor status with high sensitivity and specificity. We used Friedman's test and Wilcoxon's signed rank test to evaluate the change in HMOconcentration during the course of lactation, and Student's t test was used to compare secretors and nonsecretors. Results: A decrease (P < 0.05) in HMO concentration was observed during the course of lactation for the US mothers, corresponding to 19.3 ± 2.9 g/L for milk collected on postnatal day 10, decreasing to 8.53 ± 1.18 g/L on day 120 (repeated measures; n = 14). On postnatal day 180, the total concentration of HMOs in Malawi milk samples from secretors (6.46 ± 1.74 mg/mL) was higher (P < 0.05) than that in samples from nonsecretors (5.25 ± 2.55 mg/mL ). The same trend was observed for fucosylated species; the concentrationwas higher in Malawimilk samples from secretors (4.91 ± 1.22mg/mL) than from nonsecretors (3.42 ± 2.27 mg/mL) (P < 0.05). Conclusions: HMOs significantly decrease during the course of lactation. Secretor milk contains higher concentrations of total and fucosylated HMOs than does nonsecretor milk. These HMO concentrations can be correlated to the health of breastfed infants in order to investigate the protective effects ofmilk components. The trialswere registered at clinicaltrials.gov as NCT01817127 and NCT00524446.",
keywords = "Fucosylation, Human milk oligosaccharides, Lactation, Mass spectrometry, Secretor",
author = "Gege Xu and Davis, {Jasmine C C} and Elisha Goonatilleke and Smilowitz, {Jennifer T.} and German, {J. Bruce} and Lebrilla, {Carlito B}",
year = "2017",
doi = "10.3945/jn.116.238279",
language = "English (US)",
volume = "147",
pages = "117--124",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "1",

}

TY - JOUR

T1 - Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation

AU - Xu, Gege

AU - Davis, Jasmine C C

AU - Goonatilleke, Elisha

AU - Smilowitz, Jennifer T.

AU - German, J. Bruce

AU - Lebrilla, Carlito B

PY - 2017

Y1 - 2017

N2 - Background: The quantitation of human milk oligosaccharides (HMOs) is challenging because of the structural complexity and lack of standards. Objective: The objective of our study was to rapidly measure the absolute concentrations of HMOs in milk using LC-mass spectrometry (MS) and to determine the phenotypic secretor status of the mothers. Methods: This quantitative method for measuring HMO concentration was developed by using ultraperformance LC multiple reaction monitoring MS. It was validated and applied to milk samples from Malawi (88 individuals; 88 samples from postnatal month 6) and the United States (Davis, California; 45 individuals, mean age: 32 y; 103 samples collected on postnatal days 10, 26, 71, or 120, repeated measures included). The concentrations of a(1,2)-fucosylated HMOs were used to determine the mothers' phenotypic secretor status with high sensitivity and specificity. We used Friedman's test and Wilcoxon's signed rank test to evaluate the change in HMOconcentration during the course of lactation, and Student's t test was used to compare secretors and nonsecretors. Results: A decrease (P < 0.05) in HMO concentration was observed during the course of lactation for the US mothers, corresponding to 19.3 ± 2.9 g/L for milk collected on postnatal day 10, decreasing to 8.53 ± 1.18 g/L on day 120 (repeated measures; n = 14). On postnatal day 180, the total concentration of HMOs in Malawi milk samples from secretors (6.46 ± 1.74 mg/mL) was higher (P < 0.05) than that in samples from nonsecretors (5.25 ± 2.55 mg/mL ). The same trend was observed for fucosylated species; the concentrationwas higher in Malawimilk samples from secretors (4.91 ± 1.22mg/mL) than from nonsecretors (3.42 ± 2.27 mg/mL) (P < 0.05). Conclusions: HMOs significantly decrease during the course of lactation. Secretor milk contains higher concentrations of total and fucosylated HMOs than does nonsecretor milk. These HMO concentrations can be correlated to the health of breastfed infants in order to investigate the protective effects ofmilk components. The trialswere registered at clinicaltrials.gov as NCT01817127 and NCT00524446.

AB - Background: The quantitation of human milk oligosaccharides (HMOs) is challenging because of the structural complexity and lack of standards. Objective: The objective of our study was to rapidly measure the absolute concentrations of HMOs in milk using LC-mass spectrometry (MS) and to determine the phenotypic secretor status of the mothers. Methods: This quantitative method for measuring HMO concentration was developed by using ultraperformance LC multiple reaction monitoring MS. It was validated and applied to milk samples from Malawi (88 individuals; 88 samples from postnatal month 6) and the United States (Davis, California; 45 individuals, mean age: 32 y; 103 samples collected on postnatal days 10, 26, 71, or 120, repeated measures included). The concentrations of a(1,2)-fucosylated HMOs were used to determine the mothers' phenotypic secretor status with high sensitivity and specificity. We used Friedman's test and Wilcoxon's signed rank test to evaluate the change in HMOconcentration during the course of lactation, and Student's t test was used to compare secretors and nonsecretors. Results: A decrease (P < 0.05) in HMO concentration was observed during the course of lactation for the US mothers, corresponding to 19.3 ± 2.9 g/L for milk collected on postnatal day 10, decreasing to 8.53 ± 1.18 g/L on day 120 (repeated measures; n = 14). On postnatal day 180, the total concentration of HMOs in Malawi milk samples from secretors (6.46 ± 1.74 mg/mL) was higher (P < 0.05) than that in samples from nonsecretors (5.25 ± 2.55 mg/mL ). The same trend was observed for fucosylated species; the concentrationwas higher in Malawimilk samples from secretors (4.91 ± 1.22mg/mL) than from nonsecretors (3.42 ± 2.27 mg/mL) (P < 0.05). Conclusions: HMOs significantly decrease during the course of lactation. Secretor milk contains higher concentrations of total and fucosylated HMOs than does nonsecretor milk. These HMO concentrations can be correlated to the health of breastfed infants in order to investigate the protective effects ofmilk components. The trialswere registered at clinicaltrials.gov as NCT01817127 and NCT00524446.

KW - Fucosylation

KW - Human milk oligosaccharides

KW - Lactation

KW - Mass spectrometry

KW - Secretor

UR - http://www.scopus.com/inward/record.url?scp=85009247654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009247654&partnerID=8YFLogxK

U2 - 10.3945/jn.116.238279

DO - 10.3945/jn.116.238279

M3 - Article

VL - 147

SP - 117

EP - 124

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 1

ER -